BGLAP and prostate cancer: Verification in a mouse tibial injection model confirmed that exosomes overexpressing miR-1275 reduce osteocalcin (OCN) expression in bone tissue and exacerbate osteolytic damage, providing a mechanistic explanation for the coexistence of osteolytic and osteoblastic lesions in clinical prostate cancer bone metastasis (120).